title: Hemolytic uremic syndrome after renal transplantation: immunosuppressive therapy with rapamycin.
authors.forename: P
authors.initials: P
authors.lastname: Heering
authors.forename: C E
authors.initials: CE
authors.lastname: Deppe
authors.forename: F
authors.initials: F
authors.lastname: Farokhzad
authors.forename: U
authors.initials: U
authors.lastname: Helmchen
authors.forename: B
authors.initials: B
authors.lastname: Grabensee
mesh_terms: D000328:Adult; D003586:Cytomegalovirus Infections / Q000150:complications; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus